Cambridge Investment Research Advisors, Inc. Trans Medics Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,128 shares of TMDX stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,128
Previous 11,692
29.39%
Holding current value
$1.81 Million
Previous $787,000
157.56%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TMDX
# of Institutions
419Shares Held
30MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$431 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$317 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$155 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$127 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$115 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.82B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...